Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling
Authors:
- 1 August 2015
- journal article
- Published by Elsevier in Neuroscience
- Vol. 301, 563-575
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30772233, 81071063, 81271212)
This publication has 77 references indexed in Scilit:
- CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120PLOS ONE, 2013
- Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 miceJournal of Neuroinflammation, 2012
- Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured NeuronsJournal of Biological Chemistry, 2010
- Functional Interactions between Stress and the Endocannabinoid System: From Synaptic Signaling to Behavioral OutputJournal of Neuroscience, 2010
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modalityLife Sciences, 2010
- δ-Opioid receptor activation attenuates oxidative injury in the ischemic rat brainBMC Biology, 2009
- Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosisBiochemical Pharmacology, 2009
- JNK signaling in apoptosisOncogene, 2008
- Pharmacotherapeutic targeting of the endocannabinoid signaling system: Drugs for obesity and the metabolic syndromePhysiology & Behavior, 2008
- Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioningBritish Journal of Pharmacology, 2008